Does EVOLOCUMAB Cause Covid-19? 473 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 473 reports of Covid-19 have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.3% of all adverse event reports for EVOLOCUMAB.
473
Reports of Covid-19 with EVOLOCUMAB
0.3%
of all EVOLOCUMAB reports
17
Deaths
108
Hospitalizations
How Dangerous Is Covid-19 From EVOLOCUMAB?
Of the 473 reports, 17 (3.6%) resulted in death, 108 (22.8%) required hospitalization, and 5 (1.1%) were considered life-threatening.
Is Covid-19 Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 473 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Covid-19?
NIRMATRELVIR\RITONAVIR (22,066)
OCRELIZUMAB (11,454)
ADALIMUMAB (9,138)
DUPILUMAB (6,986)
RITUXIMAB (6,301)
LENALIDOMIDE (6,223)
TOFACITINIB (4,926)
SECUKINUMAB (3,871)
INFLIXIMAB (3,698)
TACROLIMUS (3,201)
Which EVOLOCUMAB Alternatives Have Lower Covid-19 Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE